Journal of International Obstetrics and Gynecology ›› 2017, Vol. 44 ›› Issue (6): 686-689.

Previous Articles     Next Articles

Advances in the Treatment of Vulvar Squamous Cell

NI Xue,ZHANG San-yuan   

  1. Shanxi Medical University,Taiyuan 030001,China(NI Xue);Department of Obstetrics and Gynecology,The First Affiliated Hospital of Shanxi Medical University,Taiyuan 030001,China(ZHANG San-yuan)
  • Received:2017-08-10 Revised:2017-09-27 Published:2017-12-15 Online:2017-12-15
  • Contact: ZHANG San-yuan,E-mail:zsyprofessor@aliyun.com E-mail:zsyprofessor@yahoo.com.cn;zsyprofessor@aliyun.com

Abstract: Vulvar cancer account for 3% to 5% of all female genital cancers. The commonest histological type is squamous cell carcinoma of the vulva. It is frequently found in postmenopausal women and increases with age. The early symptoms of squamous cell carcinoma of the vulva are not specific, and late symptoms of pruritus, pain, irritation and increased secretions can delay diagnosis and treatment. At present, the diagnosis is still based on biopsy, and biopsy of asymptomatic suspects is also necessary. For the treatment of early stage of squamous cell carcinoma of the vulva, surgical resection is usually performed, and radiotherapy, chemotherapy and targeted therapy are adopted in the later stage, because of the low morbidity, a standard treatment regimen has not been established. In recent years, there have been new progresses in surgery, radiotherapy, chemotherapy and other fields for vulvar squamous cell carcinoma. So this article gives an overview on treatment of vulvar squamous carcinoma so as to provide reference for this disease.

Key words: Vulvar neoplasms, Carcinoma, squamous cell, Therapy

CLC Number: